
Actionable spontaneous antibody responses antagonize malignant progression in ovarian carcinoma (1286)
Publication
, Conference
Handley, K; Mehta, S; Martin, A; Biswas, S; Maharaj, K; Nagy, M; Mine, J; Cortina, C; Yu, X; Sprenger, K; Mandal, G; Innamarato, P; Powers, J ...
Published in: Gynecologic Oncology
September 2023
Duke Scholars
Published In
Gynecologic Oncology
DOI
ISSN
0090-8258
Publication Date
September 2023
Volume
176
Start / End Page
S178 / S179
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 3215 Reproductive medicine
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1114 Paediatrics and Reproductive Medicine
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Handley, K., Mehta, S., Martin, A., Biswas, S., Maharaj, K., Nagy, M., … Conejo-Garcia, J. (2023). Actionable spontaneous antibody responses antagonize malignant progression in ovarian carcinoma (1286). In Gynecologic Oncology (Vol. 176, pp. S178–S179). Elsevier BV. https://doi.org/10.1016/j.ygyno.2023.06.192
Handley, Katelyn, Sumit Mehta, Alexandra Martin, Subir Biswas, Kamira Maharaj, Mate Nagy, Jessica Mine, et al. “Actionable spontaneous antibody responses antagonize malignant progression in ovarian carcinoma (1286).” In Gynecologic Oncology, 176:S178–79. Elsevier BV, 2023. https://doi.org/10.1016/j.ygyno.2023.06.192.
Handley K, Mehta S, Martin A, Biswas S, Maharaj K, Nagy M, et al. Actionable spontaneous antibody responses antagonize malignant progression in ovarian carcinoma (1286). In: Gynecologic Oncology. Elsevier BV; 2023. p. S178–9.
Handley, Katelyn, et al. “Actionable spontaneous antibody responses antagonize malignant progression in ovarian carcinoma (1286).” Gynecologic Oncology, vol. 176, Elsevier BV, 2023, pp. S178–79. Crossref, doi:10.1016/j.ygyno.2023.06.192.
Handley K, Mehta S, Martin A, Biswas S, Maharaj K, Nagy M, Mine J, Cortina C, Yu X, Sprenger K, Mandal G, Innamarato P, Powers J, Harro C, Chaurio R, Anadon Galindo CM, Shahzad M, Flores I, Conejo-Garcia J. Actionable spontaneous antibody responses antagonize malignant progression in ovarian carcinoma (1286). Gynecologic Oncology. Elsevier BV; 2023. p. S178–S179.

Published In
Gynecologic Oncology
DOI
ISSN
0090-8258
Publication Date
September 2023
Volume
176
Start / End Page
S178 / S179
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 3215 Reproductive medicine
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1114 Paediatrics and Reproductive Medicine
- 1112 Oncology and Carcinogenesis